Atrial septal defect closure.
Congenital heart disease accounted for 0.3% of US hospital admissions in 2007, with 48% related to atrial septal defects (ASDs). More than one-fourth of adult congenital heart defects are ASDs, 75% of which are ostium secundum ASDs. The progressive impact of volume overload of the right cardiac chambers can be halted by ASD closure. This review focuses on percutaneous ASD closure.
Division of Cardiology, Washington University School of Medicine, St Louis, MO 63110, USA.
Andres F
AF
Vasquez
John M
JM
Lasala
D000328:Adult; D000758:Anesthesia / Q000379:methods; D021721:Balloon Occlusion / Q000295:instrumentation / Q000379:methods; D006328:Cardiac Catheterization / Q000295:instrumentation / Q000379:methods*; D002983:Clinical Competence / Q000592:standards; D000075202:Contraindications; D017548:Echocardiography, Transesophageal; D005471:Fluoroscopy / Q000379:methods; D006344:Heart Septal Defects, Atrial / Q000473:pathology / Q000503:physiopathology / Q000628:therapy*; D006439:Hemodynamics; D006801:Humans; D008505:Medical Staff, Hospital / Q000458:organization & administration / Q000592:standards; D010348:Patient Care Team / Q000458:organization & administration; D018579:Patient Selection; D011474:Prosthesis Design; D019919:Prosthesis Implantation / Q000295:instrumentation / Q000379:methods; D055989:Septal Occluder Device; D013503:Surgery Department, Hospital / Q000458:organization & administration
Adults; Atrial septal defect; Percutaneous closure; Septal closure device